The clinical, biochemical and genetic features associated with RMND1-related mitochondrial disease

DSpace/Manakin Repository

The clinical, biochemical and genetic features associated with RMND1-related mitochondrial disease

Citable link to this page

 

 
Title: The clinical, biochemical and genetic features associated with RMND1-related mitochondrial disease
Author: Ng, Yi Shiau; Alston, Charlotte L; Diodato, Daria; Morris, Andrew A; Ulrick, Nicole; Kmoch, Stanislav; Houštěk, Josef; Martinelli, Diego; Haghighi, Alireza; Atiq, Mehnaz; Gamero, Montserrat Anton; Garcia-Martinez, Elena; Kratochvílová, Hana; Santra, Saikat; Brown, Ruth M; Brown, Garry K; Ragge, Nicola; Monavari, Ahmad; Pysden, Karen; Ravn, Kirstine; Casey, Jillian P; Khan, Arif; Chakrapani, Anupam; Vassallo, Grace; Simons, Cas; McKeever, Karl; O'Sullivan, Siobhan; Childs, Anne-Marie; Østergaard, Elsebet; Vanderver, Adeline; Goldstein, Amy; Vogt, Julie; Taylor, Robert W; McFarland, Robert

Note: Order does not necessarily reflect citation order of authors.

Citation: Ng, Y. S., C. L. Alston, D. Diodato, A. A. Morris, N. Ulrick, S. Kmoch, J. Houštěk, et al. 2016. “The clinical, biochemical and genetic features associated with RMND1-related mitochondrial disease.” Journal of Medical Genetics 53 (11): 768-775. doi:10.1136/jmedgenet-2016-103910. http://dx.doi.org/10.1136/jmedgenet-2016-103910.
Full Text & Related Files:
Abstract: Background: Mutations in the RMND1 (Required for Meiotic Nuclear Division protein 1) gene have recently been linked to infantile onset mitochondrial disease characterised by multiple mitochondrial respiratory chain defects. Methods: We summarised the clinical, biochemical and molecular genetic investigation of an international cohort of affected individuals with RMND1 mutations. In addition, we reviewed all the previously published cases to determine the genotype–phenotype correlates and performed survival analysis to identify prognostic factors. Results: We identified 14 new cases from 11 pedigrees that harbour recessive RMND1 mutations, including 6 novel variants: c.533C>A, p.(Thr178Lys); c.565C>T, p.(Gln189*); c.631G>A, p.(Val211Met); c.1303C>T, p.(Leu435Phe); c.830+1G>A and c.1317+1G>T. Together with all previously published cases (n=32), we show that congenital sensorineural deafness, hypotonia, developmental delay and lactic acidaemia are common clinical manifestations with disease onset under 2 years. Renal involvement is more prevalent than seizures (66% vs 44%). In addition, median survival time was longer in patients with renal involvement compared with those without renal disease (6 years vs 8 months, p=0.009). The neurological phenotype also appears milder in patients with renal involvement. Conclusions: The clinical phenotypes and prognosis associated with RMND1 mutations are more heterogeneous than that were initially described. Regular monitoring of kidney function is imperative in the clinical practice in light of nephropathy being present in over 60% of cases. Furthermore, renal replacement therapy should be considered particularly in those patients with mild neurological manifestation as shown in our study that four recipients of kidney transplant demonstrate good clinical outcome to date.
Published Version: doi:10.1136/jmedgenet-2016-103910
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264221/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:31731796
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters